Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19
Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham, et al.
The Science of The Total Environment (2020) Vol. 749, pp. 141364-141364
Open Access | Times Cited: 377
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 66
Disparities in Age-specific Morbidity and Mortality From SARS-CoV-2 in China and the Republic of Korea
Joseph P. Dudley, Nam Taek Lee
Clinical Infectious Diseases (2020) Vol. 71, Iss. 15, pp. 863-865
Open Access | Times Cited: 129
Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?
Carlo Brogna, Barbara Brogna, Domenico Rocco Bisaccia, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 708-708
Open Access | Times Cited: 46
Ion-Exchange Chromatography Coupled to Mass Spectrometry in Life Science, Environmental, and Medical Research
Judith B. Ngere, Kourosh Honarmand Ebrahimi, R. Jordan Williams, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 1, pp. 152-166
Open Access | Times Cited: 34
Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification
Carlo Brogna, Vincenzo Costanzo, Barbara Brogna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3929-3929
Open Access | Times Cited: 25
Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19
Emily Happy Miller, Medini K. Annavajhala, Alexander M. Chong, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 43
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways
Laure‐Alix Clerbaux, Julija Filipovska, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5400-5400
Open Access | Times Cited: 30
Markers Associated with COVID-19 Susceptibility, Resistance, and Severity
Aisha D. Fakhroo, Asmaa A. Al Thani, Hadi M. Yassine
Viruses (2020) Vol. 13, Iss. 1, pp. 45-45
Open Access | Times Cited: 39
NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy
Rosa Giugliano, Assunta Sellitto, Carlo Ferravante, et al.
Microbial Pathogenesis (2022) Vol. 165, pp. 105506-105506
Open Access | Times Cited: 26
The first report on detecting SARS-CoV-2 inside bacteria of the human gut microbiome: A case series on asymptomatic family members and a child with COVID-19
Carlo Brogna, Simone Cristoni, Mauro Petrillo, et al.
F1000Research (2024) Vol. 11, pp. 135-135
Open Access | Times Cited: 5
Toxin-like Peptides from the Bacterial Cultures Derived from Gut Microbiome Infected by SARS-CoV-2—New Data for a Possible Role in the Long COVID Pattern
Carlo Brogna, Simone Cristoni, Barbara Brogna, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 87-87
Open Access | Times Cited: 19
Oropharyngeal resistome remains stable during COVID-19 therapy, while fecal resistome shifts towards a less diverse resistotype
Elizaveta V. Starikova, Julia S. Galeeva, Dmitry E. Fedorov, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111319-111319
Open Access | Times Cited: 2
An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota
Shaoshuai Li, Yang Zhou, Dongmei Yan, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1774-1774
Open Access | Times Cited: 12
Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS‐CoV‐2
Jovan Dragelj, María Andrea Mroginski, Kourosh Honarmand Ebrahimi
ChemBioChem (2021) Vol. 22, Iss. 20, pp. 2946-2950
Open Access | Times Cited: 13
A lipidomic view of SARS-CoV-2
Kourosh Honarmand Ebrahimi, James McCullagh
Bioscience Reports (2021) Vol. 41, Iss. 8
Open Access | Times Cited: 10
Multi-structural molecular docking (MOD) combined with molecular dynamics reveal the structural requirements of designing broad-spectrum inhibitors of SARS-CoV-2 entry to host cells
Anqi Da, Meritxell Wu‐Lu, Jovan Dragelj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Fecal Shedding of SARS-CoV-2 and Its Potential Role in Person-To-Person Transmission and the Environment-Based Spread of COVID-19
Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham, et al.
(2020)
Open Access | Times Cited: 7
Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase
Esen Sokullu, Maxime Pinard, Marie‐Soleil Gauthier, et al.
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 8, pp. 881-895
Open Access | Times Cited: 6
Two years into COVID‐19 – Lessons in SARS‐CoV‐2 and a perspective from papers in FEBS Letters
Urs F. Greber
FEBS Letters (2021) Vol. 595, Iss. 23, pp. 2847-2853
Open Access | Times Cited: 5
The first report on detecting SARS-CoV-2 inside bacteria of the human gut microbiome: A case series on asymptomatic family members and a child with COVID-19
Carlo Brogna, Simone Cristoni, Mauro Petrillo, et al.
F1000Research (2022) Vol. 11, pp. 135-135
Open Access | Times Cited: 3
Is the Gut Microbiome a Target for Adjuvant Treatment of COVID-19?
Kai Hilpert
Biologics (2021) Vol. 1, Iss. 3, pp. 285-299
Open Access | Times Cited: 4
The Effect of SARS-CoV-2 on the Gut and Its Microbiome: What We Know and What We Would Like to Know
N. V. Evdokimova, T. V. Chernenkaya
Russian Sklifosovsky Journal Emergency Medical Care (2024) Vol. 12, Iss. 4, pp. 658-666
Open Access
Microbiota of upper respiratory tract in COVID-19
Г. Ш. Исаева, Nikita S. Chumarev
Clinical Microbiology and Antimicrobial Chemotherapy (2024) Vol. 26, Iss. 1, pp. 21-30
Open Access
The upper respiratory tract microbiome and its role in human health: barrier function
Elizaveta V. Starikova, Julia S. Galeeva, Elena N. Ilina
PULMONOLOGIYA (2022) Vol. 32, Iss. 6, pp. 876-884
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top